Association Between Oral Isotretinoin Therapy and Unmasked Latent Immuno-mediated Diabetes

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2009 Jul 30

PMID 19638521

Citations 7

Authors

Ilaria Dicembrini

Gianluca Bardini

Carlo M Rotella

Affiliations

Soon will be listed here.

Citing Articles

Isotretinoin is not associated with an increased risk of diabetes: a retrospective cohort study.

Garate D, Thang C, Lai J, Golovko G, Wilkerson M, Barbieri J Arch Dermatol Res. 2025; 317(1):341.

PMID: 39912858 DOI: 10.1007/s00403-025-03876-x.

The Effect of Isotretinoin on Insulin Resistance and Serum Adiponectin Levels in Acne Vulgaris Patients: A Systematic Review and Meta-Analysis.

Paschalidou E, Katsaras G, Papoulakis T, Kalloniati E, Kavvadas D, Karachrysafi S Clin Pract. 2024; 14(3):1021-1037.

PMID: 38921259 PMC: 11202953. DOI: 10.3390/clinpract14030081.

Side Effects of Treating Acne Vulgaris With Isotretinoin: A Systematic Review.

Rajput I, Anjankar V Cureus. 2024; 16(3):e55946.

PMID: 38601403 PMC: 11004850. DOI: 10.7759/cureus.55946.

Unraveling the Mechanism of Immunity and Inflammation Related to Molecular Signatures Crosstalk Among Obesity, T2D, and AD: Insights From Bioinformatics Approaches.

Vishal K, Bhuiyan P, Qi J, Chen Y, Zhang J, Yang F Bioinform Biol Insights. 2023; 17:11779322231167977.

PMID: 37124128 PMC: 10134115. DOI: 10.1177/11779322231167977.

Skin and metabolic syndrome: A review of the possible associations.

Adibi N, Robati R J Res Med Sci. 2021; 26:16.

PMID: 34084195 PMC: 8106409. DOI: 10.4103/jrms.JRMS_585_20.

References

Koistinen H, Remitz A, Gylling H, Miettinen T, Koivisto V, Ebeling P . Dyslipidemia and a reversible decrease in insulin sensitivity induced by therapy with 13-cis-retinoic acid. Diabetes Metab Res Rev. 2001; 17(5):391-5. DOI: 10.1002/dmrr.222. View

Rodondi N, Darioli R, Ramelet A, Hohl D, Lenain V, Perdrix J . High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study. Ann Intern Med. 2002; 136(8):582-9. DOI: 10.7326/0003-4819-136-8-200204160-00007. View

Poitout V, Robertson R . Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev. 2007; 29(3):351-66. PMC: 2528858. DOI: 10.1210/er.2007-0023. View

Cnop M . Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes. Biochem Soc Trans. 2008; 36(Pt 3):348-52. DOI: 10.1042/BST0360348. View